Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Grem

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
Journal of the National Cancer Institute|March 15, 1989
Pentostatin in hairy cell leukemia: treatment by the special exception mechanismJ L Grem, S A King, B D Cheson, et al.
Anti-Cancer Drugs|July 19, 2001
Peripheral neuropathy associated with weekly oral 5-fluorouracil, leucovorin and eniluracilM W Saif, R H Wilson, N Harold, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|June 8, 2001
Measurement of the novel antitumor agent 17-(allylamino)-17-demethoxygeldanamycin in human plasma by high-performance liquid chromatographyE B Agnew, R H Wilson, J L Grem, et al.
British Journal of Cancer|December 1, 1994
Determinants of trimetrexate lethality in human colon cancer cellsJ L Grem, D M Voeller, F Geoffroy, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
AntimetabolitesJ L Grem, B A Chabner, E Chu, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
AntimetabolitesC J Allegra, J L Grem, E Chu, et al.
Investigational New Drugs|May 1, 1990
Clinical toxicity associated with tiazofurinJ L Grem, L Rubinstein, S A King, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
AntimetabolitesE Chu, J L Grem, P G Johnston, et al.
Biochemical Pharmacology|November 29, 1994
Cytotoxicity and metabolism of 4-methoxy-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine in HCT 116 colon cancer cellsJ L Grem, P Daychild, J Drake, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
AntimetabolitesP G Johnston, C H Takimoto, J L Grem, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Journal of the National Cancer Institute|March 15, 1989
Pentostatin in hairy cell leukemia: treatment by the special exception mechanismJ L Grem, S A King, B D Cheson, et al.
Anti-Cancer Drugs|July 19, 2001
Peripheral neuropathy associated with weekly oral 5-fluorouracil, leucovorin and eniluracilM W Saif, R H Wilson, N Harold, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|June 8, 2001
Measurement of the novel antitumor agent 17-(allylamino)-17-demethoxygeldanamycin in human plasma by high-performance liquid chromatographyE B Agnew, R H Wilson, J L Grem, et al.
British Journal of Cancer|December 1, 1994
Determinants of trimetrexate lethality in human colon cancer cellsJ L Grem, D M Voeller, F Geoffroy, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
AntimetabolitesJ L Grem, B A Chabner, E Chu, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
AntimetabolitesC J Allegra, J L Grem, E Chu, et al.
Investigational New Drugs|May 1, 1990
Clinical toxicity associated with tiazofurinJ L Grem, L Rubinstein, S A King, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
AntimetabolitesE Chu, J L Grem, P G Johnston, et al.
Biochemical Pharmacology|November 29, 1994
Cytotoxicity and metabolism of 4-methoxy-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine in HCT 116 colon cancer cellsJ L Grem, P Daychild, J Drake, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
AntimetabolitesP G Johnston, C H Takimoto, J L Grem, et al.
Pageof 12